- Health Spotlight's Achondroplasia Insights
- Posts
- Weekly Spotlight - 14.11.24
Weekly Spotlight - 14.11.24
Innovative treatments, financial progress, and inspiring stories.
Community |
Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters! |
In the News |
Achondroplasia: Understanding, Managing, and Thriving with Dwarfism |
Achondroplasia is a genetic disorder affecting bone growth, leading to short stature. It is often caused by a spontaneous mutation and can be diagnosed through physical exams and DNA testing. While there is no cure, supportive treatments and community resources help individuals lead fulfilling lives. |
Tyra Biosciences Announces Promising Q3 2024 Financial and Clinical Updates |
Tyra Biosciences reports promising results for TYRA-300 in cancer treatment, showing positive anti-tumour activity. The company plans to expand studies and has received FDA clearance for a paediatric achondroplasia trial. Financially, Tyra remains strong with significant cash reserves, supporting ongoing and future research initiatives. |
Andrew Smith's Inspiring Journey: From Surgery to Charity Success |
Andrew Smith, living with dwarfism, celebrates five years as an Essex Police dispatcher. Despite spinal surgery and job application challenges, he advocates pursuing dreams. Smith, also a charity cyclist and business owner, finds support in his workplace and community, emphasising the importance of accessible adaptations for disabilities. |
Nicole Meyer, an Aberdeen mother, advocates for dwarfism awareness, inspired by her son Henry, who has the condition. As a physician's assistant, she uses her platform to promote understanding and support for those with dwarfism, highlighting the importance of inclusivity and community engagement in Aberdeen and beyond. |
Health Spotlight’s Achondroplasia is a Contentive publication in the Healthcare division